NEWTOWN, Pa.--(BUSINESS WIRE)--BioClinica®, Inc., (NASDAQ: BIOC), a global provider of clinical trial management services, announced today that Sanofi (EURONEXT: SAN and NYSE: SNY), one of the world’s largest pharmaceutical companies, has selected BioClinica’s OnPoint as the company’s standard CTMS (Clinical Trial Management System). With this decision, Sanofi plans to utilize OnPoint CTMS for all clinical trial management activity.
